The difficult task of finding the best antihypertensive agent: Comment on “Antihypertensive treatment and development of heart failure in hypertension”

There are a few silent epidemics in medicine, and heart failure certainly is one of them. There are good reasons to care about it: End-stage HF is more deadly than most cancers, and only recently has the idea of HF with preserved ejection fraction been transformed into being accepted as diastolic he...

Full description

Saved in:
Bibliographic Details
Main Author: Frankenstein, Lutz (Author)
Format: Article (Journal) Editorial
Language:English
Published: 2011
In: Archives of internal medicine
Year: 2011, Volume: 171, Issue: 5, Pages: 394-395
ISSN:1538-3679
DOI:10.1001/archinternmed.2010.414
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1001/archinternmed.2010.414
Get full text
Author Notes:Lutz Frankenstein, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1837511918
003 DE-627
005 20230710094244.0
007 cr uuu---uuuuu
008 230227s2011 xx |||||o 00| ||eng c
024 7 |a 10.1001/archinternmed.2010.414  |2 doi 
035 |a (DE-627)1837511918 
035 |a (DE-599)KXP1837511918 
035 |a (OCoLC)1389738003 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Frankenstein, Lutz  |d 1973-  |e VerfasserIn  |0 (DE-588)124198937  |0 (DE-627)63440766X  |0 (DE-576)328373281  |4 aut 
245 1 4 |a The difficult task of finding the best antihypertensive agent  |b Comment on “Antihypertensive treatment and development of heart failure in hypertension”  |c Lutz Frankenstein, MD 
264 1 |c 2011 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: November 8, 2010 
500 |a Gesehen am 27.02.2023 
520 |a There are a few silent epidemics in medicine, and heart failure certainly is one of them. There are good reasons to care about it: End-stage HF is more deadly than most cancers, and only recently has the idea of HF with preserved ejection fraction been transformed into being accepted as diastolic heart failure. Now diastolic HF is interesting for 2 reasons: (1) it is more common in women—a subgroup notoriously underdiagnosed, undertreated, and underrepresented in clinical trials; and (2) from a global perspective, one of the major risk factors for its development is hypertension and the ensuing hypertensive heart disease. Hypertension, however, does not only lead to diastolic HF but, from a global perspective, it represents the major risk factor for the development of HF as such. 
773 0 8 |i Enthalten in  |t Archives of internal medicine  |d [Chicago, Ill.] : Assoc., 1960  |g 171(2011), 5 vom: März, Seite 394-395  |h Online-Ressource  |w (DE-627)268760853  |w (DE-600)1473069-8  |w (DE-576)088704106  |x 1538-3679  |7 nnas  |a The difficult task of finding the best antihypertensive agent Comment on “Antihypertensive treatment and development of heart failure in hypertension” 
773 1 8 |g volume:171  |g year:2011  |g number:5  |g month:03  |g pages:394-395  |g extent:2  |a The difficult task of finding the best antihypertensive agent Comment on “Antihypertensive treatment and development of heart failure in hypertension” 
787 0 8 |i Ergänzung zu  |a Sciarretta, Sebastiano  |t Antihypertensive treatment and development of heart failure in hypertension, in: Archives of internal medicine  |g 171(2011,5) vom: März, Seite 384-394, DOI 10.1001/archinternmed.2010.427 
856 4 0 |u https://doi.org/10.1001/archinternmed.2010.414  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230227 
993 |a Editorial 
994 |a 2011 
998 |g 124198937  |a Frankenstein, Lutz  |m 124198937:Frankenstein, Lutz  |d 910000  |d 910100  |e 910000PF124198937  |e 910100PF124198937  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j  |y j 
999 |a KXP-PPN1837511918  |e 4276860172 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1837511918","id":{"doi":["10.1001/archinternmed.2010.414"],"eki":["1837511918"]},"name":{"displayForm":["Lutz Frankenstein, MD"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"language":["eng"],"note":["Online veröffentlicht: November 8, 2010","Gesehen am 27.02.2023"],"person":[{"family":"Frankenstein","role":"aut","display":"Frankenstein, Lutz","given":"Lutz"}],"relHost":[{"titleAlt":[{"title":"Archives of internal medicine (1960)"}],"note":["Gesehen am 18.08.25"],"pubHistory":["Vol. 106, no. 1 (July 1, 1960)-vol. 172, no 22 (December 10/24, 2012)"],"id":{"eki":["268760853"],"zdb":["1473069-8"],"issn":["1538-3679"]},"disp":"The difficult task of finding the best antihypertensive agent Comment on “Antihypertensive treatment and development of heart failure in hypertension”Archives of internal medicine","corporate":[{"role":"isb","display":"American Medical Association"}],"origin":[{"publisher":"Assoc.","dateIssuedKey":"1960","publisherPlace":"[Chicago, Ill.]","dateIssuedDisp":"1960-2012"}],"title":[{"title_sort":"Archives of internal medicine","title":"Archives of internal medicine"}],"language":["eng"],"recId":"268760853","type":{"bibl":"periodical","media":"Online-Ressource"},"name":{"displayForm":["American Medical Association"]},"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"171","text":"171(2011), 5 vom: März, Seite 394-395","issue":"5","year":"2011","pages":"394-395","extent":"2"}}],"title":[{"title_sort":"difficult task of finding the best antihypertensive agent","subtitle":"Comment on “Antihypertensive treatment and development of heart failure in hypertension”","title":"The difficult task of finding the best antihypertensive agent"}],"physDesc":[{"extent":"2 S."}]} 
SRT |a FRANKENSTEDIFFICULTT2011